Viruses within theFlaviviridaeDecrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells
- 15 December 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (12) , 7860-7869
- https://doi.org/10.4049/jimmunol.0902276
Abstract
Viral infections alter host cell homeostasis and this may lead to immune evasion and/or interfere with the replication of other microbes in coinfected hosts. Two flaviviruses are associated with a reduction in HIV replication or improved survival in HIV-infected people (dengue virus (DV) and GB virus type C (GBV-C)). GBV-C infection and expression of the GBV-C nonstructural protein 5A (NS5A) and the DV NS5 protein in CD4+ T cells inhibit HIV replication in vitro. To determine whether the inhibitory effect on HIV replication is conserved among other flaviviruses and to characterize mechanism(s) of HIV inhibition, the NS5 proteins of GBV-C, DV, hepatitis C virus, West Nile virus, and yellow fever virus (YFV; vaccine strain 17D) were expressed in CD4+ T cells. All NS5 proteins inhibited HIV replication. This correlated with decreased steady-state CD4 mRNA levels and reduced cell surface CD4 protein expression. Infection of CD4+ T cells and macrophages with YFV (17D vaccine strain) also inhibited HIV replication and decreased CD4 gene expression. In contrast, mumps virus was not inhibited by the expression of flavivirus NS5 protein or by YFV infection, and mumps infection did not alter CD4 mRNA or protein levels. In summary, CD4 gene expression is decreased by all human flavivirus NS5 proteins studied. CD4 regulation by flaviviruses may interfere with innate and adaptive immunity and contribute to in vitro HIV replication inhibition. Characterization of the mechanisms by which flaviviruses regulate CD4 expression may lead to novel therapeutic strategies for HIV and immunological diseases.Keywords
This publication has 65 references indexed in Scilit:
- GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapyAIDS, 2009
- Characterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV ReplicationPLOS ONE, 2008
- Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In VitroJournal of Virology, 2007
- Viral Interactions in Human Lymphoid Tissue: Human Herpesvirus 7 Suppresses the Replication of CCR5-Tropic Human Immunodeficiency Virus Type 1 via CD4 ModulationJournal of Virology, 2007
- An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4 + Jurkat T cellsProceedings of the National Academy of Sciences, 2006
- Replication of West Nile virus in equine peripheral blood mononuclear cellsVeterinary Immunology and Immunopathology, 2006
- GB Virus Type C NS5A Sequence Polymorphisms: Association with Interferon Susceptibility and Inhibition of PKR-Mediated eIF2α PhosphorylationJournal of Interferon & Cytokine Research, 2005
- Hepatitis C virus NS5A: tales of a promiscuous proteinJournal of General Virology, 2004
- Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophagesBlood, 2004
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984